The Conservative Alliance

Reader,
It’s Big Pharma’s WORST nightmare…
A disease-fighting breakthrough so powerful it won TWO Nobel Prizes.
The discovery of a dormant “Second Immune System” inside your body…
That when reawakened has defeated ALL of the worst chronic diseases in major human clinical trials.
A prestigious Ivy League medical school reports it “Induces the death of metastatic progression.” Duke University says it’s “critical for maintaining muscle and heart function.” Johns Hopkins finds “Brain neurons [become] resistant to the kind of damage associated with brain aging and even stroke.”
>>> Scientists have documented the ability of this two-time winning Nobel Prize therapy ([link removed]) to spontaneously regrow diseased and dying organs — brain, stomach, kidney, lung, liver, skin, you name it.
Even better…
This drug-free therapy for all disease won’t cost you a dime. Which has Big Pharma terrified…
They stand to lose billions if word spreads.
And are fighting tooth-and-nail to keep this off the public radar.
Click here to discover the two-time winning Nobel Prize therapy that has Big Pharma running scared. ([link removed])

To Your Good Health,

Al Sears, MD, CNS
If you don't want to receive this type of emails anymore, you can unsubscribe ([link removed]).
View our privacy policy ([link removed])
MATERIAL CONNECTION DISCLOSURE: You should assume that the sender of this email has an affiliate relationship and/or another material connection to the persons or businesses mentioned in this message and may receive commissions from purchases you make on subsequent web sites. You should not rely solely on information contained in this email to evaluate the product or service being endorsed. Always exercise due diligence before purchasing any product or service.

The above message from our advertising sponsor. The products, views, and offerings made by advertisers are not necessarily endorsed by Us.

© 2020 The Conservative Alliance
Conservative Alliance Org
848 N. Rainbow Blvd. #3975 Las Vegas, NV 89107

You are subscribed to this email as [email protected]. Click here to modify your preferences [link removed] or unsubscribe [link removed].